This study is part of the research on type 1 narcolepsy, a neurological pathology affecting mostly young subjects. The only biomarker currently available is the hypocretin assay, which shows a level below 110 pg/mL. However, the interpretation of this biomarker has limitations: the test is not widely available and it is rarely performed by practitioners. Even when performed, the interpretation of the level may not be consistent with the phenotype compatible with type 1 narcolepsy. This study therefore aims to develop new tools to reduce the diagnostic delay. This would be the first study with 7T MRI that could achieve a level of spatial resolution sufficient to highlight volume changes in small brain structures such as the lateral hypothalamus whose narcolepsy-induced changes are not detected by lower resolution MRI.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
30
Patients and healthy volunteers will have a 7T MRI
Service Epileptologie et Rythmologie Cérébrale, Centre du Sommeil
Marseille, France
RECRUITINGHypothalamic morphological difference
Significant structural size difference between right and left lateral hypothalamus
Time frame: Month 0
Microstructural abnormalities other than volume differences
Significant difference in Diffusion and T2\* values in the lateral hypothalamus
Time frame: Month 0
Structural changes in hypothalamic nuclei other than the lateral hypothalamus
Significant difference in volumes and T1 values in other regions of the posterior hypothalamus
Time frame: Month 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.